These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 10479300

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
    Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G.
    J Med Chem; 2004 Jan 29; 47(3):550-7. PubMed ID: 14736236
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M, Pierce WM, Chen D, Zimmerman TJ.
    Exp Eye Res; 1994 Jan 29; 58(1):107-16. PubMed ID: 8157096
    [Abstract] [Full Text] [Related]

  • 24. Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold.
    Casini A, Mincione F, Vullo D, Menabuoni L, Scozzafava A, Supuran CT.
    J Enzyme Inhib Med Chem; 2002 Feb 29; 17(1):9-18. PubMed ID: 12365464
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties.
    Casini A, Scozzafava A, Mincione F, Menabuoni L, Supuran CT.
    J Enzyme Inhib Med Chem; 2002 Oct 29; 17(5):333-43. PubMed ID: 12683750
    [Abstract] [Full Text] [Related]

  • 27. Carbonic anhydrase inhibitors: novel compounds containing S-NH moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I, II and IV.
    Scozzafava A, Supuran CT.
    J Enzyme Inhib; 1998 Sep 29; 13(6):419-42. PubMed ID: 9825306
    [Abstract] [Full Text] [Related]

  • 28. Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents.
    Maestrelli F, Mura P, Casini A, Mincione F, Scozzafava A, Supuran CT.
    J Pharm Sci; 2002 Oct 29; 91(10):2211-9. PubMed ID: 12226848
    [Abstract] [Full Text] [Related]

  • 29. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A, Winum JY, Innocenti A, Vullo D, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5775-80. PubMed ID: 15501039
    [Abstract] [Full Text] [Related]

  • 30. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties.
    Mincione F, Starnotti M, Menabuoni L, Scozzafava A, Casini A, Supuran CT.
    Bioorg Med Chem Lett; 2001 Jul 09; 11(13):1787-91. PubMed ID: 11425561
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F, Innocenti A, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Scozzafava A, Temperini C, Supuran CT.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3933-40. PubMed ID: 18242998
    [Abstract] [Full Text] [Related]

  • 34. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM, Parkkila S, Vullo D, Casini A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3757-62. PubMed ID: 15203157
    [Abstract] [Full Text] [Related]

  • 35. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M, Supuran CT.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9113-20. PubMed ID: 18819811
    [Abstract] [Full Text] [Related]

  • 36. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.
    Scozzafava A, Briganti F, Ilies MA, Supuran CT.
    J Med Chem; 2000 Jan 27; 43(2):292-300. PubMed ID: 10649985
    [Abstract] [Full Text] [Related]

  • 37. Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates.
    Brechue WF, Maren TH.
    J Pharmacol Exp Ther; 1993 Feb 27; 264(2):670-5. PubMed ID: 8437114
    [Abstract] [Full Text] [Related]

  • 38. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
    Carta F, Pothen B, Maresca A, Tiwari M, Singh V, Supuran CT.
    Chem Biol Drug Des; 2009 Aug 27; 74(2):196-202. PubMed ID: 19549076
    [Abstract] [Full Text] [Related]

  • 39. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
    Innocenti A, Firnges MA, Antel J, Wurl M, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1149-54. PubMed ID: 15686931
    [Abstract] [Full Text] [Related]

  • 40. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups.
    Bozdag M, Ferraroni M, Carta F, Vullo D, Lucarini L, Orlandini E, Rossello A, Nuti E, Scozzafava A, Masini E, Supuran CT.
    J Med Chem; 2014 Nov 13; 57(21):9152-67. PubMed ID: 25310626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.